316 related articles for article (PubMed ID: 18564398)
41. Transfusion-related alloimmune neutropenia with no pulmonary complications: one donor-five cases.
Hauck-Dlimi B; Ruppel R; Zimmermann R; Strobel J; Reil A; Eckstein R; Zingsem J
Transfusion; 2016 Jan; 56(1):84-90. PubMed ID: 26388439
[TBL] [Abstract][Full Text] [Related]
42. The effect of double- and triple-apheresis platelet product donation on apheresis donor platelet and white blood cell counts.
Richa E; Krueger P; Burgstaler EA; Bryant SC; Winters JL
Transfusion; 2008 Jul; 48(7):1325-32. PubMed ID: 18346017
[TBL] [Abstract][Full Text] [Related]
43. Testing platelet mass versus platelet count to guide platelet transfusions in the neonatal intensive care unit.
Gerday E; Baer VL; Lambert DK; Paul DA; Sola-Visner MC; Pysher TJ; Christensen RD
Transfusion; 2009 Oct; 49(10):2034-9. PubMed ID: 19555422
[TBL] [Abstract][Full Text] [Related]
44. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets.
Levy L; Woodfield DG
N Z Med J; 1984 Oct; 97(766):719-21. PubMed ID: 6595558
[TBL] [Abstract][Full Text] [Related]
45. Generation of inflammatory cytokines and chemokines from peripheral blood mononuclear cells by HLA Class II antibody-containing plasma unit that was associated with severe nonhemolytic transfusion reactions.
Sakagawa H; Miyazaki T; Fujihara M; Sato S; Yamaguchi M; Fukai K; Morioka M; Kato T; Azuma H; Ikeda H
Transfusion; 2007 Jan; 47(1):154-61. PubMed ID: 17207244
[TBL] [Abstract][Full Text] [Related]
46. A bead-based assay in the work-up of suspected platelet alloimmunization.
Cooper N; Bein G; Heidinger K; Santoso S; Sachs UJ
Transfusion; 2016 Jan; 56(1):115-8. PubMed ID: 26545411
[TBL] [Abstract][Full Text] [Related]
47. Human platelet antigen systems in allogeneic peripheral blood progenitor cell transplantation: effect of human platelet antigen mismatch on platelet engraftment and graft-versus-host disease.
García-Malo MD; Corral J; González M; Solano C; González-Conejero R; Caballero MD; Pérez R; Moraleda JM; Vicente V
Transfusion; 2004 May; 44(5):771-6. PubMed ID: 15104661
[TBL] [Abstract][Full Text] [Related]
48. Complement (C1q) fixing solid-phase screening for HLA antibodies increases the availability of compatible platelet components for refractory patients.
Fontaine MJ; Kuo J; Chen G; Galel SA; Miller E; Sequeira F; Viele M; Goodnough LT; Tyan DB
Transfusion; 2011 Dec; 51(12):2611-8. PubMed ID: 21615749
[TBL] [Abstract][Full Text] [Related]
49. Lack of antibody formation to platelet neoantigens after transfusion of riboflavin and ultraviolet light-treated platelet concentrates.
Ambruso DR; Thurman G; Marschner S; Goodrich RP
Transfusion; 2009 Dec; 49(12):2631-6. PubMed ID: 19694996
[TBL] [Abstract][Full Text] [Related]
50. Rapid detection of HPA-1 alloantibodies by platelet antigens immobilized onto microbeads.
Bakchoul T; Meyer O; Agaylan A; Bombard S; Bein G; Sachs UJ; Salama A; Santoso S
Transfusion; 2007 Aug; 47(8):1363-8. PubMed ID: 17655579
[TBL] [Abstract][Full Text] [Related]
51. [Severe neonatal alloimmune thrombocytopenia with delayed antibody detection].
Schabel A; König AL; Brand U; Schnaidt M; Sugg U
Beitr Infusionsther Transfusionsmed; 1996; 33():156-9. PubMed ID: 8974689
[TBL] [Abstract][Full Text] [Related]
52. Amotosalen interactions with platelet and plasma components: absence of neoantigen formation after photochemical treatment.
Lin L; Conlan MG; Tessman J; Cimino G; Porter S
Transfusion; 2005 Oct; 45(10):1610-20. PubMed ID: 16181212
[TBL] [Abstract][Full Text] [Related]
53. External quality assessment of platelet serology and human platelet antigen genotyping: a 10-year review.
Porcelijn L; van Beers W; Gratama JW; van't Veer M; De Smet A; Sintnicolaas K
Transfusion; 2008 Aug; 48(8):1699-706. PubMed ID: 18482186
[TBL] [Abstract][Full Text] [Related]
54. A national survey of transfusion-related acute lung injury risk reduction policies for platelets and plasma in the United States.
Kleinman S; Grossman B; Kopko P
Transfusion; 2010 Jun; 50(6):1312-21. PubMed ID: 20456690
[TBL] [Abstract][Full Text] [Related]
55. The lack of correlation between the positivity of anti-platelet antibodies and the presence of thrombocytopenia in course of HIV infection.
Riccio A; Natale D; Fratellanza G; Infranzi E; Farinaro C; Pronesti G; Casiere D; Tullio Cataldo P; Chirianni A; Bonadies G
Boll Soc Ital Biol Sper; 1993 Mar; 69(3):203-8. PubMed ID: 8129899
[TBL] [Abstract][Full Text] [Related]
56. Reticulated platelets: a reliable measure to reduce prophylactic platelet transfusions after intensive chemotherapy.
Chaoui D; Chakroun T; Robert F; Rio B; Belhocine R; Legrand O; Salanoubat C; Lecrubier C; Casadevall N; Marie JP; Elalamy I
Transfusion; 2005 May; 45(5):766-72. PubMed ID: 15847667
[TBL] [Abstract][Full Text] [Related]
57. The detection of platelet antibodies by simultaneous analysis of specific platelet antibodies and the monoclonal antibody-specific immobilization of platelet antigens: an interlaboratory comparison.
Nguyen XD; Goebel M; Schober M; Klüter H; Panzer S
Transfusion; 2010 Jul; 50(7):1429-34. PubMed ID: 20456677
[TBL] [Abstract][Full Text] [Related]
58. Patient and product factors affecting platelet transfusion results.
Heim D; Passweg J; Gregor M; Buser A; Theocharides A; Arber C; Meyer-Monard S; Halter J; Tichelli A; Gratwohl A
Transfusion; 2008 Apr; 48(4):681-7. PubMed ID: 18208413
[TBL] [Abstract][Full Text] [Related]
59. How much residual plasma may cause TRALI?
Win N; Chapman CE; Bowles KM; Green A; Bradley S; Edmondson D; Wallis JP
Transfus Med; 2008 Oct; 18(5):276-80. PubMed ID: 18937733
[TBL] [Abstract][Full Text] [Related]
60. Platelet alloimmunization after long-term red cell transfusion in transfusion-dependent thalassemia patients.
Lo SC; Chang JS; Lin SW; Lin DT
Transfusion; 2005 May; 45(5):761-5. PubMed ID: 15847666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
